Relevant secondary outcomes by GA stratification
| All PH | PH before 72 h | Open-label Rx | ||||
|---|---|---|---|---|---|---|
| GA (weeks) | Indo | Placebo | Indo | Placebo | Indo | Placebo |
| 23 | 1/1 | 0/1 | 1/1 | 0/1 | 1/1 | 1/1 |
| 24 | 1/7 | 2/7 | 0/7 | 2/7 | 2/7 | 6/7 |
| 25 | 0/7 | 3/4 | 0/7 | 3/4 | 2/7 | 3/4 |
| 26 | 2/8 | 4/12 | 0/8 | 4/12 | 4/8 | 5/12 |
| 27 | 0/14 | 2/15 | 0/14 | 1/15 | 0/14 | 3/15 |
| 28 | 0/7 | 0/9 | 0/7 | 0/9 | 0/7 | 1/9 |
| Total | 4/44 | 11/48 | 1/44 | 10/48 | 9/44 | 19/48 |
GA, gestational age; PH, pulmonary haemorrhage.